Cemvita, an emerging frontier AI lab for industrial BioSolutions, today announced a partnership with Roebling, an AI-native engineering firm, to speed the discovery, evaluation and deployment of biological solutions for the natural-resource industries.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261014308515/en/

Cemvita and Roebling are combining Cemvita’s proprietary biological data and industrial biotechnology expertise with Roebling’s AI-native process engineering and techno-economic modeling to accelerate the de-risking of BioSolutions from discovery to commercial deployment.

Cemvita and Roebling are combining Cemvita’s proprietary biological data and industrial biotechnology expertise with Roebling’s AI-native process engineering and techno-economic modeling to accelerate the de-risking of BioSolutions from discovery to commercial deployment.

Cemvita brings more than a decade of experience developing and scaling industrial biotechnology, along with proprietary biological, fermentation, process and deployment data. Through its BioSolutions Discovery Platform, the company applies these capabilities to energy, mining, chemicals, agriculture, water, waste and other natural-resource industries.

Roebling will serve as Cemvita’s engineering partner, adding AI-native process engineering and techno-economic modeling to the platform. Together, the companies will bring engineering, economic and commercial insight into development much earlier, helping Cemvita find the most viable pathways, focus its de-risking work and prepare promising BioSolutions for deployment.

“Industrial biotechnology has never lacked promising discoveries. The challenge has been knowing early enough which technologies can become commercially viable, financeable and deployable projects,” said Moji Karimi, CEO and Co-Founder of Cemvita. “Our domain expertise and proprietary data give us the foundation for a differentiated AI platform for industrial BioSolutions. Roebling helps us turn that intelligence into process configurations, project economics and deployment pathways much faster, so we can complete early de-risking sooner and increase the rate at which BioSolutions reach industry.”

Industrial projects have traditionally moved through sequential engineering cycles: technical development, then process design, then economic evaluation, then formal front-end loading (FEL). Critical commercial constraints can take months or years to surface. By using Roebling to evaluate plant configurations, capacities, feedstocks, locations, utility needs, capital and operating costs, and commercial sensitivities from the start, Cemvita expects to shorten parts of the analysis that inform FEL decisions from months to weeks.

This earlier insight will allow Cemvita to:

  • Compare more technical and commercial pathways before committing significant capital.
  • Identify the variables that most affect project viability, and design de-risking programs around them.
  • Eliminate weak opportunities sooner.
  • Advance stronger BioSolutions into formal engineering and deployment with greater confidence.

The initial collaboration will center on a configurable model of Cemvita’s FermWorks process, built from its existing Basis of Design. Roebling will run analysis across plant sizes, feedstocks, locations, process configurations and product mixes. The companies expect to extend the work to other opportunities in Cemvita’s growing BioSolutions portfolio. As individual projects advance, Roebling may also support customer-specific technical evaluation, pre-front-end engineering design (pre-FEED), FEL and deployment.

“Cemvita brings deep industrial-biotechnology expertise, proprietary data and a portfolio of real deployment opportunities,” said Edward Shenderovich, CEO and Co-Founder of Roebling. “We want to be Cemvita’s engineering partner at every stage, turning that knowledge into faster engineering and investment decisions and a more efficient path from biological possibility to industrial project.”

About Cemvita

Cemvita is building a frontier AI lab for industrial BioSolutions. Through its BioSolutions Discovery Platform, the company combines artificial intelligence, microbial intelligence, proprietary data and industrial-biotechnology expertise to discover, de-risk and deploy biological solutions for the natural-resource industries. Its work spans biological production, resource recovery, process improvement and environmental applications, backed by experience scaling biotechnology from the laboratory to industrial operations. For more information, visit www.cemvita.com.

About Roebling

Roebling is an AI-native engineering firm that partners with industrial companies to evaluate, design and advance projects, from early technical assessment through investment and deployment. Its engineers use physics-grounded AI models that connect process design, engineering assumptions and project economics, giving clients faster and more transparent answers to capital decisions. For more information, visit www.roebling.com.

Media gallery

About The Author
Business Wire